Sai's research focuses on translating PET radiotracers from
bench to bedside, specifically developing and evaluating first-in-class PET
radiotracers for imaging novel imaging biomarkers including microtubules,
G-protein coupled receptor 39, 119 to facilitate the early detection of
Alzheimer's disease and related dementia. He holds a BS in chemistry, biochemistry,
and microbiology, as well as an MS in organic chemistry from Osmania University
in Hyderabad, India. He received his PhD in organic chemistry from Northern
Illinois University in DeKalb, Illinois, and completed his postdoctoral
training at Washington University in St. Louis School of Medicine.
Established in 2023, the SNMMI Mars Shot Research Fund is a forward-looking
glimpse into the future of nuclear medicine. It provides resources that
translate visionary nuclear medicine imaging, radiopharmaceutical therapy, and
data science research or projects into tools or treatments that will help
improve the lives of patients.
###
About the Society of Nuclear Medicine and Molecular Imaging
The Society of Nuclear Medicine and Molecular Imaging
(SNMMI) is an international scientific and medical organization dedicated to
advancing nuclear medicine, molecular imaging, and theranostics precision
medicine that allows diagnosis and treatment to be tailored to individual
patients in order to achieve the best possible
outcomes. For more information, visit snmmi.org.